TEVA PHARMACEUTICALS INTERNATIONAL GMBH;LABRYS BIOLOGICS INC.
发明人:
申请号：
IL24802516
公开号：
IL248025D0
申请日:
2016.09.25
申请国别(地区):
IL
年份:
2016
代理人:
摘要：
The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms, including headaches (e.g., migraine, cluster headache, and tension headache) and hot flushes, by administering an anti-CGRP antagonist antibody. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.
